Steven B.  Ketchum net worth and biography

Steven Ketchum Biography and Net Worth

Insider of Amarin

Dr. Steven B. Ketchum is the president of research and development and senior vice president of Amarin Corporation, an Irish biopharmaceutical company. 

Ketchum has nearly 30 years of experience in clinical regulatory strategy and late-stage product development from leading the filings of many successful new drug applications (NDAs). Since joining Amarin in 2012, Ketchum has led the company’s drug discovery, preclinical and clinical development program, and regulatory and medical affairs activities. He was also elected to Amarin’s board of directors in 2012.

Prior to his role at Amarin, Ketchum was the senior vice president of research and development at Sunesis Pharmaceuticals where he guided all areas of pharmaceutical research, clinical development and strategy, and regulatory affairs. 

The pharmaceutical leader also has held the titles of senior vice president of research and development and medical affairs and senior vice president of operations and regulatory affairs for Reliant Pharmaceuticals and IntraBiotics Pharmaceuticals, Inc., respectively. 

Ketchum began his career by gaining extensive experience in regulatory affairs with ALZA, a pharmaceutical and medical supplies company where he worked for eight years ending in 2004. 

Ketchum earned his Ph.D. in pharmacology at the University College London in 1990 and his B.S. in biological sciences at Stanford University.

What is Steven B. Ketchum's net worth?

The estimated net worth of Steven B. Ketchum is at least $283,050.00 as of December 12th, 2023. Mr. Ketchum owns 566,100 shares of Amarin stock worth more than $283,050 as of November 16th. This net worth evaluation does not reflect any other assets that Mr. Ketchum may own. Additionally, Mr. Ketchum receives a salary of $1,160,000.00 as Insider at Amarin. Learn More about Steven B. Ketchum's net worth.

How old is Steven B. Ketchum?

Mr. Ketchum is currently 59 years old. There are 5 older executives and no younger executives at Amarin. The oldest executive at Amarin is Mr. Aaron D. Berg, Executive VP & President of U.S., who is 61 years old. Learn More on Steven B. Ketchum's age.

What is Steven B. Ketchum's salary?

As the Insider of Amarin Co. plc, Mr. Ketchum earns $1,160,000.00 per year. The highest earning executive at Amarin is Mr. Aaron D. Berg, Executive VP & President of U.S., who commands a salary of $1,260,000.00 per year. Learn More on Steven B. Ketchum's salary.

How do I contact Steven B. Ketchum?

The corporate mailing address for Mr. Ketchum and other Amarin executives is 77 Sir John Rogerson`s Quay Block C Grand Canal Docklands, Dublin L2, Dublin 2. Amarin can also be reached via phone at (531) 669-9020 and via email at [email protected]. Learn More on Steven B. Ketchum's contact information.

Has Steven B. Ketchum been buying or selling shares of Amarin?

Steven B. Ketchum has not been actively trading shares of Amarin over the course of the past ninety days. Most recently, Steven B. Ketchum sold 34,131 shares of the business's stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $0.79, for a transaction totalling $26,963.49. Following the completion of the sale, the insider now directly owns 566,100 shares of the company's stock, valued at $447,219. Learn More on Steven B. Ketchum's trading history.

Who are Amarin's active insiders?

Amarin's insider roster includes Michael Kalb (CFO), Joseph Kennedy (General Counsel), Steven Ketchum (Insider), David Stack (Director), and Joseph Zakrzewski (Director). Learn More on Amarin's active insiders.

Are insiders buying or selling shares of Amarin?

During the last twelve months, Amarin insiders bought shares 2 times. They purchased a total of 174,426 shares worth more than $118,124.34. During the last twelve months, insiders at the biopharmaceutical company sold shares 1 times. They sold a total of 34,131 shares worth more than $26,963.49. The most recent insider tranaction occured on August, 2nd when CEO Aaron Berg bought 160,000 shares worth more than $102,400.00. Insiders at Amarin own 2.0% of the company. Learn More about insider trades at Amarin.

Information on this page was last updated on 8/2/2024.

Steven B. Ketchum Insider Trading History at Amarin

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2023Sell34,131$0.79$26,963.49566,100View SEC Filing Icon  
2/1/2021Sell217,728$8.06$1,754,887.68425,069View SEC Filing Icon  
1/27/2021Sell421,629$8.01$3,377,248.29556,893View SEC Filing Icon  
4/30/2019Sell9,541$18.67$178,130.47View SEC Filing Icon  
4/1/2019Sell9,542$20.06$191,412.52View SEC Filing Icon  
3/1/2019Sell55,543$21.85$1,213,614.55View SEC Filing Icon  
2/1/2019Sell37,530$17.17$644,390.10View SEC Filing Icon  
12/31/2018Sell17,041$13.51$230,223.91View SEC Filing Icon  
11/30/2018Sell17,042$17.79$303,177.18View SEC Filing Icon  
10/31/2018Sell17,042$20.74$353,451.08View SEC Filing Icon  
10/1/2018Sell316,604$16.13$5,106,822.52View SEC Filing Icon  
9/25/2018Sell879,241$11.10$9,759,575.10View SEC Filing Icon  
1/23/2018Sell135,205$4.41$596,254.05View SEC Filing Icon  
1/11/2018Sell2,612$4.40$11,492.80View SEC Filing Icon  
1/5/2018Sell64,683$4.40$284,605.20View SEC Filing Icon  
1/2/2018Sell128,257$4.25$545,092.25View SEC Filing Icon  
10/5/2017Sell63,479$3.48$220,906.92View SEC Filing Icon  
See Full Table

Steven B. Ketchum Buying and Selling Activity at Amarin

This chart shows Steven B Ketchum's buying and selling at Amarin by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amarin Company Overview

Amarin logo
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $0.50
Low: $0.50
High: $0.52

50 Day Range

MA: $0.59
Low: $0.50
High: $0.63

2 Week Range

Now: $0.50
Low: $0.50
High: $1.37

Volume

2,005,382 shs

Average Volume

1,531,844 shs

Market Capitalization

$205.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.92